The increased prevalence of hypertension and dyslipidaemia specifically in the young population necessitates the identification and quantification of literature gaps in the different phases (awareness, screening, diagnosis, treatment, adherence, and control) of patient management in the UAE for better clinical outcomes. This semi-systematic review identified relevant articles through structured and unstructured searches. Studies on adult populations published (2010-2019) in English and providing data on phases of management of hypertension or dyslipidaemia in the UAE were retrieved. Quantitative data were represented as weighted means. In total, 11 studies on hypertension and six studies on dyslipidaemia were included for the final analyses. The pooled prevalence of hypertension and dyslipidaemia was 24.8% and 43.8%, respectively. The estimates indicated that a few patients (range: 6.8%-17.3%) were aware of their condition, where 63.2% and 49.3% were screened for hypertension or dyslipidaemia, respectively. Approximately two-thirds of patients were on antihypertensive and lipid-lowering medications, whereas 68.4% of patients were adherent to antihypertensive treatment. No data are available on adherence to dyslipidaemia treatment. Control of both risk factors was poor (range: 12.7%-27.8%). The semi-systematic approach identified limited to no data on different phases of management of hypertension and dyslipidaemia, indicating a need for generating country-specific real-world data.